SCHEMBL2163370

SCHEMBL2163370

C[NH-].C[NH-].[GeH2+2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11877663 0.75
SCHEMBL3170875 0.75
SCHEMBL11655088 0.75
Lithium Ion SCHEMBL555214 0.75
Potassium Ion SCHEMBL6403371 0.75
SCHEMBL7055335 0.75
SCHEMBL2163365 0.75
SCHEMBL13279661 0.75
Lithium Ion SCHEMBL11877317 0.67
Potassium Ion SCHEMBL11659725 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110180905-A1 GeSbTe MATERIAL INCLUDING SUPERFLOW LAYER(S), AND USE OF Ge TO PREVENT INTERACTION OF Te FROM SbXTeY AND GeXTeY RESULTING IN HIGH Te CONTENT AND FILM CRYSTALLINITY ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2011-07-28 US claimed
WO-2009152108-A2 GeSbTe MATERIAL INCLUDING SUPERFLOW LAYER(S), AND USE OF Ge TO PREVENT INTERACTION OF Te FROM SbXTeY AND GeXTeY RESULTING IN HIGH Te CONTENT AND FILM CRISTALLINITY ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2009-12-17 WO claimed
US-20110180905-A1 GeSbTe MATERIAL INCLUDING SUPERFLOW LAYER(S), AND USE OF Ge TO PREVENT INTERACTION OF Te FROM SbXTeY AND GeXTeY RESULTING IN HIGH Te CONTENT AND FILM CRYSTALLINITY ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2011-07-28 US disclosed
WO-2009152108-A2 GeSbTe MATERIAL INCLUDING SUPERFLOW LAYER(S), AND USE OF Ge TO PREVENT INTERACTION OF Te FROM SbXTeY AND GeXTeY RESULTING IN HIGH Te CONTENT AND FILM CRISTALLINITY ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2009-12-17 WO disclosed